| Literature DB >> 23304138 |
Fadzillah Mohd-Tahir1, A Norhayati, Ishak Siti-Raihan, M Ibrahim.
Abstract
Background. Corneal blindness from healed infected keratitis is one of the most preventable causes of monocular blindness in developing countries, including Malaysia. Our objectives were to identify the causative fungi, predisposing risk factors, the proportion of correct clinical diagnosis, and visual outcome of patients treated in our hospital. Methods. A retrospective review of medical and microbiology records was conducted for all patients who were treated for fungal keratitis at Hospital Universiti Sains Malaysia from January 2007 until December 2011. Results. Forty-seven patients (47/186, 25.27%) were treated for fungal keratitis during the study period. This demonstrated that the incidence of fungal keratitis has increased each year from 2007 to 2011 by 12.50%, 17.65%, 21.21%, 26.83%, and 28.57%, respectively. The most common predisposing factors were injury to the eye followed by use of topical steroid, and preexisting ocular surface disease. Fusarium species were the most common fungal isolated, followed by Candida species. Clinical diagnosis of fungal keratitis was made in 26 of the 41 (63.41%) cases of positive isolates. Of these, in eleven cases (23.40%) patients required surgical intervention. Clinical outcome of healed scar was achieved in 34 (72.34%) cases. Conclusions. The percentage of positive fungal isolated has steadily increased and the trend of common fungal isolated has changed. The latest review regarding fungal keratitis is important for us to improve patients' outcome in the future.Entities:
Year: 2012 PMID: 23304138 PMCID: PMC3533451 DOI: 10.1155/2012/851563
Source DB: PubMed Journal: Interdiscip Perspect Infect Dis ISSN: 1687-708X
Figure 1Age and sex distributions of patients with fungal keratitis at Hospital Universiti Sains Malaysia from 2007 until 2011.
Type of fungal ulcer from corneal scrapping.
| Type of fungal | No of cases (%) |
|---|---|
| Hyaline | |
|
| 19 (46%) |
|
| 4 (9.75%) |
|
| 1 (2.44%) |
|
| 1 (2.44%) |
|
| 1 (2.44%) |
| Yeast | |
|
| 2 (4.87%) |
|
| 2 (4.87%) |
|
| 1 (2.44%) |
| Dematiaceous | |
|
| 2 (4.87%) |
| Nonsporulating fungi | 3 (7.31%) |
| Unidentified hyaline | 4 (9.75%) |
| Unidentified yeast | 1 (2.44%) |
Figure 2Comparison between numbers of positive fungal isolates, correct clinical diagnosis, and presumed cases of fungal keratitis.
Treatment modalities and outcome according to each fungal isolates.
| Type of fungal ( | Vision at presentation | Vision posttreatment | |||||||
|---|---|---|---|---|---|---|---|---|---|
| <6/18 | 6/18–1/60 | CF-PL | NPL | Treatment | less than 6/18 | 6/18–1/60 | CF-PL | NPL | |
| Hyaline | |||||||||
|
| 6 | 4 | 9 | G. Natamycin if available, G. Amphotericin. B, Oral & Gut Fluconazole. 5 PK, 1 evisceration | 10 | 3 | 4 | 2 | |
|
| 1 | 3 | G. Natamycin, Voriconazole, Amphotericin B | 3 | 1 | ||||
|
| 1 | Gutt Amphotericin B & Voriconazole. Oral Voriconazole. | 1 | ||||||
|
| 1 | Gutt. Ciprofloxacin (Provisional diagnosis: marginal keratitis) | 1 | ||||||
|
| 1 | Gutt. Amphotericin B & Fluconazole. Oral Fluconazole. | 1 | ||||||
|
| |||||||||
| Yeast | |||||||||
|
| 1 | 1 | Gutt Amphotericin B | 1 | 1 | ||||
|
| 1 | 1 | Gutt Amphotericin B | 1 | 1 | ||||
| (infected cornea graft) | Repeat penetrating keratoplasty | ||||||||
|
| 1 | Gutt Amphotericin B | 1 | ||||||
| (Ocular ischaemic syndrome) | |||||||||
|
| |||||||||
| Dermatiaceous | |||||||||
|
| 2 | Gutt. Amphotericin B | 2 | ||||||
|
| |||||||||
| Nonsporulating fungi (3) | 1 | 2 | Gutt. Amphotericin B | 2 | 1 | ||||
|
| |||||||||
| Unidentified hyaline (4) | 1 | 3 | All required systemic + topical treatment | 2 | 2 | ||||
|
| |||||||||
| Unidentified yeast (1) | 1 | Gutt Amphotericin B | 1 | ||||||
Abbreviations: CF: counting finger, PK: penetrating keratoplasty, NPL: no perception of light, PL: perception of light.